Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7503449 | Drug and Alcohol Dependence | 2017 | 6 Pages |
Abstract
Most buprenorphine prescribers practice well under their current patient limit and have numerous months with no patient episodes. For the few high prescribers, increasing the maximum patient limit beyond 100 has the potential to improve access but alone may not have widespread impact unless integrated into complementary approaches toward increasing prescriber capacity.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Cindy Parks Thomas, Erin Doyle, Peter W. Kreiner, Christopher M. Jones, Joel Dubenitz, Alexis Horan, Bradley D. Stein,